Financial Incentives for Quitting Smoking
(FIESTA II Trial)

Recruiting in Palo Alto (17 mi)

+1 other location

Overseen byScott Sherman, MD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: University of California, Los Angeles

No Placebo Group

Trial Summary

What is the purpose of this trial?

Financial incentives for motivating changes in health behavior, particularly for smoking and other morbid habits, are increasingly being tested by health insurers, employers, and government agencies. However, in using incentive programs for smoking cessation, key unanswered structural and theoretical questions remain regarding their effectiveness, acceptability to patients, and economic sustainability. This trial aims to advance the science and implementation of financial incentives for smoking cessation interventions among high-risk, hospitalized smokers. The investigators will pursue two specific aims: 1) comparing the impact of three approaches for smoking cessation on smoking abstinence, use of evidenced-based therapy, and quality of life and 2) comparing the short-term and long term return on investment of using goal directed and outcome-based financial incentives to promote smoking cessation.

Research Team

Joseph Ladapo, MD, PhD

Principal Investigator

University of California, Los Angeles

Scott Sherman, MD

Principal Investigator

NYU Langone Health

Eligibility Criteria

This trial is for adults over 18 who have smoked tobacco in the last month, are considering quitting smoking, and can consent in English or Spanish. They must have an active U.S. phone number and address. It's not for those using only smokeless tobacco, pregnant or breastfeeding individuals, people discharged to institutions like nursing homes, or anyone unable to consent.

Inclusion Criteria

have an active U.S. phone number and address

I am 18 years old or older.

I can give my consent in English or Spanish.

See 2 more

Exclusion Criteria

I am being discharged to a nursing home or long-term care facility.

I am able to understand and agree to participate in the study.

You only use smokeless tobacco products.

See 1 more

Treatment Details

Interventions

Financial incentives for smoking cessation (Behavioural Intervention)
Financial incentives for use of evidence-based smoking cessation therapies (Behavioural Intervention)
Smoking cessation counseling (Quitline) (Behavioural Intervention)
Smoking cessation pharmacotherapy (Behavioural Intervention)

Trial OverviewThe study tests if financial rewards can help hospitalized smokers quit. Participants will receive smoking cessation counseling (Quitline), pharmacotherapy (like nicotine patches), and cash incentives for quitting or using these therapies effectively.

Participant Groups

3Treatment groups

Experimental Treatment

Group I: Outcome-Based IncentivesExperimental Treatment3 Interventions

Group II: Goal-Directed IncentivesExperimental Treatment3 Interventions

Group III: Enhanced Usual CareExperimental Treatment2 Interventions